Mahamaya Lifesciences fundamental analysis

172.85

9.85 (6.04%)
Last updated on 20 Jul, 2026 | 15:29 IST

Mahamaya Lifesciences Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Good

On its scorecard, Mahamaya Lifesciences reflects: Price – Expensive, Growth – Poor, Quality – Poor, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost
Invest Now